GE HealthCare CEO reports PSU vesting, tax shares

GE HealthCare Technologies President and CEO Peter J. Arduini reported equity award activity involving company common stock.

Rhea-AI Filing Summary

GE HealthCare Technologies President and CEO Peter J. Arduini reported equity award activity involving company common stock. On February 12, 2026, he acquired 74,908 shares at $0 upon vesting of previously granted performance stock units, after performance goals were certified as met. On the same date, 33,445 shares were disposed of at $79.20 per share to satisfy tax withholding obligations related to this vesting. Following these transactions, Arduini directly beneficially owned 206,135 shares of GE HealthCare common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Arduini Peter J

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	74,908	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	33,445	$79.20	$2.65M

Holdings After Transaction: Common Stock, par value $0.01 per share — 206,135 shares (Direct)

Footnotes (2)

1. F1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026.
2. F2. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GEHC CEO Peter Arduini report on this Form 4?

Peter Arduini reported vesting of 74,908 GE HealthCare common shares from performance stock units. These PSUs were granted in March 2023 and converted one-for-one into common stock after performance criteria were certified as satisfied on February 12, 2026.

How many GEHC shares were withheld to cover taxes for Peter Arduini?

A total of 33,445 GE HealthCare common shares were withheld to cover tax obligations. This tax-withholding disposition occurred on February 12, 2026, at a price of $79.20 per share, directly tied to the vesting of performance stock units reported on the same Form 4.

What is Peter Arduini’s GEHC share ownership after these Form 4 transactions?

After the reported transactions, Peter Arduini directly beneficially owned 206,135 GE HealthCare common shares. This figure reflects the net result of the 74,908-share PSU vesting and the simultaneous 33,445-share tax withholding disposition on February 12, 2026.

Were the GEHC shares acquired by Peter Arduini open-market purchases?

No, the 74,908 GE HealthCare shares were not open-market purchases. They resulted from vesting of performance stock units granted on March 1, 2023, which converted into common stock once performance goals were satisfied and certified by the company’s compensation committee.

What performance awards are described in Peter Arduini’s GEHC Form 4?

The filing describes performance stock units granted on March 1, 2023. Each PSU entitled Arduini to one share of GE HealthCare common stock. After the company’s Talent, Culture, and Compensation Committee certified that performance criteria were met, these PSUs vested on February 12, 2026.

What transaction codes are used in GEHC CEO Peter Arduini’s Form 4?

The Form 4 shows transaction code A for the 74,908-share acquisition from PSU vesting and transaction code F for the 33,445-share tax-withholding disposition. Code A reflects a grant or award, while code F reflects using shares to satisfy tax liabilities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arduini Peter J

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/12/2026		A		74,908(1)	A	$0	239,580	D
Common Stock, par value $0.01 per share	02/12/2026		F		33,445(2)	D	$79.2	206,135	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026.

2. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.